SJIM
ALNY icon

St. Johns Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

St. Johns Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Hold
50
– – 0.01% 121
2026
Q1 		$16.5K Hold
50
– – 0.01% 117
2025
Q4 		$19.9K Hold
50
– – 0.01% 114
2025
Q3 		$22.8K Hold
50
– – 0.01% 117
2025
Q2 		$16.3K Hold
50
– – 0.01% 122
2025
Q1 		$13.5K Hold
50
– – 0.01% 120
2024
Q4 		$11.8K Hold
50
– – 0.01% 125
2024
Q3 		$13.8K Hold
50
– – 0.01% 135
2024
Q2 		$12.2K Hold
50
– – 0.01% 121
2024
Q1 		$7.47K Hold
50
– – ﹤0.01% 145
2023
Q4 		$9.57K Hold
50
– – ﹤0.01% 128
2023
Q3 		$8.86K Hold
50
– – 0.01% 126
2023
Q2 		$9.5K Hold
50
– – 0.01% 130
2023
Q1 		$10K Hold
50
– – 0.01% 119
2022
Q4 		$11.9K Hold
50
– – 0.01% 112
2022
Q3 		$10K Hold
50
– – 0.01% 117
2022
Q2 		$7K Hold
50
– – ﹤0.01% 120
2022
Q1 		$8K Hold
50
– – ﹤0.01% 130
2021
Q4 		$8K Hold
50
– – ﹤0.01% 142
2021
Q3 		$9K Hold
50
– – 0.01% 124
2021
Q2 		$8K Hold
50
– – ﹤0.01% 126
2021
Q1 		$7K Hold
50
– – ﹤0.01% 124
2020
Q4 		$6K Hold
50
– – ﹤0.01% 126
2020
Q3 		$7K Hold
50
– – ﹤0.01% 122
2020
Q2 		$7K Buy
+50
New +$6.74K 0.01% 118

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

St. Johns Investment Management's ALNY Position: Q2 2026 in Review

St. Johns Investment Management held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 50 shares worth $15.1K. The position accounts for 0.01% of the portfolio, ranked #121.

St. Johns Investment Management first reported a position in ALNY in Q2 2020 and has held it in 25 quarters since. The position peaked at $22.8K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • St. Johns Investment Management held 50 shares of Alnylam Pharmaceuticals worth $15.1K as of Q2 2026.
  • St. Johns Investment Management left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
  • Alnylam Pharmaceuticals made up 0.01% of St. Johns Investment Management's portfolio in Q2 2026, its #121 holding.
  • St. Johns Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • St. Johns Investment Management's Alnylam Pharmaceuticals position peaked at $22.8K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on St. Johns Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.